MSL
VNDA icon

Mackay Shields LLC’s Vanda Pharmaceuticals VNDA Stock Holding History

Mackay Shields LLC’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-79,622
Closed -$911K – 1559
2020
Q2 		$911K Buy
79,622
+14,800
+23% +$168K 0.01% 1058
2020
Q1 		$671K Buy
64,822
+9,200
+17% +$114K 0.01% 1066
2019
Q4 		$913K Sell
55,622
-3,200
-5% -$48.4K 0.01% 1087
2019
Q3 		$781K Sell
58,822
-6,400
-10% -$89.2K ﹤0.01% 1173
2019
Q2 		$919K Buy
65,222
+44,922
+221% +$715K 0.01% 1148
2019
Q1 		$373K Buy
+20,300
New +$463K ﹤0.01% 1237

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Mackay Shields LLC's VNDA Position: Q3 2020 in Review

Mackay Shields LLC sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 79,622 shares — an estimated $911K sold.

Mackay Shields LLC first reported a position in VNDA in Q1 2019 and held it in 6 quarters. The position peaked at $919K in Q2 2019. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

  • Mackay Shields LLC reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 79,622 Vanda Pharmaceuticals shares in Q3 2020, an estimated $911K.
  • Mackay Shields LLC first reported a position in Vanda Pharmaceuticals in Q1 2019 and held it in 6 quarters.
  • Mackay Shields LLC's Vanda Pharmaceuticals position peaked at $919K in Q2 2019.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.